FIND Study Shows Cepheid TB Test Performs Well in Remote Labs, Reduces Time to Treatment
April 21, 2011
FIND Study Shows Cepheid TB Test Performs Well in Remote Labs, Reduces Time to Treatment
The study, the second major clinical validation of the test, was published in the same week that Cepheid reported strong first-quarter results and several financial analysts raised their earnings estimates for the company.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Dx Focus: PEPFAR Funding Drives Cepheid TB Test Uptake; Curetis Starts US Trials for MDx System
December 6, 2012 / PCR Insider - Unitaid Provides $30M to Reduce Cost, Increase Uptake of Cepheid TB Test in Developing World
June 14, 2012 / PCR Insider - UNC Team Wins NIH Grant to Study Treatment Outcomes of TB Patients Diagnosed with Cepheid Test
April 12, 2012 / PCR Insider - Cepheid's TB, Drug-Resistance Assay Shines as POC Test in Developing World
September 2, 2010 / PCR Insider - Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider